NewAmsterdam Pharma Company N.V. (NAMS) Earnings
NASDAQ·Healthcare·Biotechnology
$30.55
+0.94%
Mkt Cap $3.54B
EPS — Estimate vs Actual
Mkt Cap
$3.54B
P/E
—
Fwd P/E
—
P/S
156.77
Rev TTM
—
EPS TTM
-$1.81
NASDAQ·Healthcare·Biotechnology
$30.55
+0.94%
Mkt Cap $3.54B
Mkt Cap
$3.54B
P/E
—
Fwd P/E
—
P/S
156.77
Rev TTM
—
EPS TTM
-$1.81